HOME >> BIOLOGY >> NEWS
Obtaining valid consent for doing large genetic studies in developing countries

Genetic research has the potential to improve global health by discovering what makes people susceptible or resistant to certain diseases, and what causes the diseases themselves, thereby guiding prevention efforts. Genetic studies, for example, are providing clues for scientists working on vaccines against HIV, malaria, and TB. But it is crucial, say Dave Chokshi (Wellcome Trust Centre for Human Genetics, University of Oxford) and colleagues in a policy paper in PLoS Medicine, to ensure that those who choose to participate in such research have given their fully informed consent.

While there has been much discussion setting out ethical principles for conducting medical research in low-income countries, there has been little discussion of how to apply these principles to large-scale genomic studies. The authors lay out a new set of ethical principles for obtaining ethically valid consent for such studies conducted in the developing world.

Citation: Chokshi DA, Thera MA, Parker M, Diakite M, Makani J, et al. (2007) Valid consent for genomic epidemiology in developing countries. PLoS Med 4(4): e95.

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040095

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-04-chokshi.pdf

CONTACT:

Dave Chokshi
University of Pennsylvania
School of Medicine
3434 Sansom St.
Philadelphia, PA PA 19104
United States of America
+1 225-354-6673
daveash@med.upenn.edu


ALSO FROM THE PLoS MEDICINE MAGAZINE SECTION:

A case of unstable blood pressure


'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
23-Apr-2007


Page: 1 2

Related biology news :

1. UF study first to quantify validity of DNA I.D. tool using marine snails
2. Studies validating performance of Pall prion reduction technology presented at AABB
3. Status and reproduction in humans: New evidence for the validity of evolutionary explanations
4. New results validating Pall prion reduction filter disclosed at ISBT Congress
5. Novel approach yields predictions validated by experiments
6. Encouraging results from validation study of trial of personalized treatment in breast cancer
7. Truly informed consent must include talking about future fertility, warn experts
8. How does the brain know what the right hand is doing?
9. To avoid doing more harm than good, land trusts must consider market forces when acquiring property
10. Ability to listen to 2 things at once is largely inherited, says twin study
11. Link between obesity and enlarged heart discovered by University of Arizona researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... 2020 , ... BioFactura, Inc. today announced a $1 million ... & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). ... efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at ... Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
Breaking Biology Technology:
Cached News: